Related Experiment Video
Updated: Mar 21, 2026

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
Epidemiology of Clostridium difficile Infection-Associated Reactive Arthritis in Children: An Underdiagnosed,
Daniel B Horton1, Brian L Strom2, Mary E Putt3
1Rutgers Biomedical and Health Sciences, New Brunswick, New Jersey2 Division of Pediatric Rheumatology, Department of Pediatrics, Nemours A.I. duPont Hospital for Children, Wilmington, Delaware3Center for Clinical Epidemiology and Biostatistics, Department.
Insights
Pediatric Clostridium difficile infection-associated reactive arthritis is underdiagnosed, affecting 1.4% of infected children annually. Early recognition is crucial due to potential misdiagnosis as septic arthritis.
Area of Science:
- Pediatric Rheumatology
- Infectious Diseases
- Epidemiology
Background:
- The incidence of Clostridium difficile infection (CDI) is rising in children.
- The epidemiology and clinical features of CDI-associated reactive arthritis (CDI-RA) in pediatric populations are not well understood.
Purpose of the Study:
- To determine the incidence and recognition of pediatric CDI-RA.
- To characterize the clinical features distinguishing CDI-RA in children with CDI.
Main Methods:
- A cohort and nested case-control study was conducted using electronic health records from 2004-2013 across three pediatric healthcare networks.
- 26 cases of pediatric CDI-RA were identified among 148 children screened for musculoskeletal disease associated with CDI.
- Network-matched controls with CDI but without arthritis were selected for comparison.
Main Results:
- The estimated incidence of pediatric CDI-RA was 5.0 cases per million person-years, affecting 1.4% of children with CDI annually.
- Joint symptoms typically began 10.5 days after gastrointestinal symptoms and were often accompanied by fever and rash.
- Only 35% of CDI-RA cases were correctly diagnosed; 19% were misdiagnosed as septic arthritis.
Conclusions:
- Pediatric CDI-RA is underdiagnosed and can be misdiagnosed as septic arthritis.
- Increased recognition of CDI-RA is necessary given the rising rates of pediatric CDI.
- This condition can be potentially morbid and requires better diagnostic awareness among healthcare professionals.
Importance:
The incidence of Clostridium difficile infection has increased among children. The epidemiology of pediatric C difficile infection-associated reactive arthritis is poorly understood.
Objective:
To characterize the incidence, recognition, and distinguishing clinical features of pediatric C difficile infection-associated reactive arthritis among children with C difficile infection.
Design, Setting, And Participants:
In this cohort and nested case-control study using electronic health records from January 1, 2004, to December 31, 2013, across 3 geographically diverse pediatric health care networks, we screened for reactive arthritis among 148 children between ages 2 and 21 years with diagnostic or procedural codes suggesting musculoskeletal disease associated with C difficile diagnosis or positive testing. We identified 26 cases with acute arthritis or tenosynovitis within 4 weeks before to 12 weeks after confirmed C difficile infection with (1) no alternative explanation for arthritis and (2) negative synovial cultures (if obtained). Network-matched C difficile-infected controls without arthritis were randomly selected at the time of cohort member C difficile infections.
Main Outcomes And Measures:
Incidence of C difficile infection-associated reactive arthritis was calculated based on (1) pediatric source population and (2) children with C difficile infection. Characteristics of cases and controls were compared using conditional logistic regression.
Results:
Based on the cases identified within the source population of the 3 hospital networks, we estimated that C difficile infection-associated reactive arthritis incidence was 5.0 cases per million person-years (95% CI, 3.0-7.8). Reactive arthritis affected 1.4% of children with C difficile infection yearly (95% CI 0.8%-2.3%). Joint symptoms began a median of 10.5 days after initial gastrointestinal symptoms, often accompanied by fever (n = 15 [58%]) or rash (n = 14 [54%]). Only 35% of cases of C difficile infection-associated reactive arthritis were correctly diagnosed by treating health care professionals (range across centers, 0%-64%). Five affected children (19%) were treated for presumed culture-negative septic hip arthritis despite having prior postantibiotic diarrhea and/or other involved joints. Compared with controls, cases of C difficile infection-associated reactive arthritis were less likely to have underlying chronic conditions (odds ratio [OR], 0.3; 95% CI, 0.1-0.8). Although all cases had community-onset C difficile infection and fewer comorbidities, they were more likely to be treated in emergency departments and/or hospitalized (OR, 7.1; 95% CI, 1.6-31.7).
Conclusions And Relevance:
C difficile infection-associated reactive arthritis is an underdiagnosed, potentially morbid reactive arthritis associated with C difficile infection occasionally misdiagnosed as septic arthritis. Given the rising incidence of pediatric C difficile infections, better recognition of its associated reactive arthritis is needed.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Rheumatic Heart Disease I: Introduction
Bacterial Gastroenteritis
Clinical Significance of Antibiotic Resistance
Staphylococcal Skin Infections
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

